Redeye’s more extensive comments
And OT Analytics’ corresponding [analysis]
(a private investor who follows Physitrack and is a major owner)
In short: as my own comment above. Cash flow and profitability are now in order. Growth is needed on the Wellness side for the true value to emerge. Trades at approx. \~50% discount to peers.
Edit 24.10. also adding Lind Research’s analyses here